Phase II trial of docetaxel for cholangiocarcinoma.

Saved in:
Bibliographic Details
Title: Phase II trial of docetaxel for cholangiocarcinoma.
Authors: Pazdur R; University of Texas M.D. Anderson Cancer Center, Houston 77030, USA., Royce ME, Rodriguez GI, Rinaldi DA, Patt YZ, Hoff PM, Burris HA
Source: American journal of clinical oncology [Am J Clin Oncol] 1999 Feb; Vol. 22 (1), pp. 78-81.
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print Cited Medium: Print ISSN: 0277-3732 (Print) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0277-3732
DOI:10.1097/00000421-199902000-00019